Vitamin D supplementation and glycaemic control in older adults: A cross-sectional survey
Published
August 2, 2025
Paper ID
PAP-000285
Status
Published
DOI
10.65712/tmj.test000543
Advance Services
Abstract
Background: Earlier studies of vitamin D supplementation were small or single-centre. Methods: Eligible participants were older adults. Results: Effects were consistent across prespecified subgroups. Effects were consistent across prespecified subgroups. Conclusion: Future work should test vitamin D supplementation in a pragmatic multicentre trial.
Introduction
glycaemic control remains a leading cause of avoidable harm among older adults. The cost of glycaemic control to health systems is substantial. Earlier studies of vitamin D supplementation were small or single-centre.
Earlier studies of vitamin D supplementation were small or single-centre.
Discussion
Implementation will depend on staffing, cost and local protocols. These findings suggest that vitamin D supplementation is associated with better glycaemic control in older adults. Future work should test vitamin D supplementation in a pragmatic multicentre trial.
Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded.
Future work should test vitamin D supplementation in a pragmatic multicentre trial. These findings suggest that vitamin D supplementation is associated with better glycaemic control in older adults.
Implementation will depend on staffing, cost and local protocols. Strengths include the sample size and blinded outcome assessment. Residual confounding cannot be excluded. These findings suggest that vitamin D supplementation is associated with better glycaemic control in older adults.
These findings suggest that vitamin D supplementation is associated with better glycaemic control in older adults. Future work should test vitamin D supplementation in a pragmatic multicentre trial. Residual confounding cannot be excluded.
Conclusions
Vitamin D supplementation is a reasonable option for older adults to improve glycaemic control.
References
1. Ahmed V, Farouk U, et al. Prone positioning and emergency department revisits. N Engl J Med. 2022;148(3):877-1308.
2. Yilmaz U, Dubois Z, et al. Prone positioning and in-hospital mortality. Lancet. 2015;344(4):770-1099.
3. Rossi C, Mensah M, et al. Continuous glucose monitoring and medication adherence. BMJ. 2012;218(3):774-1776.
4. Rossi Q, Kim G, et al. Tranexamic acid and chronic pain scores. Diabetes Care. 2008;341(9):852-1208.
5. Osei N, Larsen Y, et al. Point-of-care ultrasound and medication adherence. Ann Intern Med. 2023;169(11):476-1356.
6. Schmidt F, Farouk O, et al. Pharmacist-led medication review and 30-day readmission. Lancet. 2012;375(7):393-1757.
7. Costa Z, Kaur O, et al. Point-of-care ultrasound and in-hospital mortality. Ann Intern Med. 2017;314(9):514-1190.
8. Mensah O, Osei S, et al. Early enteral nutrition and emergency department revisits. Pediatrics. 2013;154(3):438-962.
9. Nakamura W, Lindqvist L, et al. Tranexamic acid and post-operative delirium. Eur Heart J. 2012;177(7):726-1688.
Appendices
Ethics approval: IRB-8227.
Materials and Methods
The primary outcome was glycaemic control, assessed blind to allocation. Analyses were adjusted for age, sex and baseline severity.
Eligible participants were older adults. The primary outcome was glycaemic control, assessed blind to allocation. Analyses were adjusted for age, sex and baseline severity. We conducted a cross-sectional survey across 3 centres between 2016 and 2022.
Results
Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.65 (95% CI 0.26 to 0.63).
glycaemic control occurred in 14% of the intervention group versus 13% of controls. Effects were consistent across prespecified subgroups.
| Group | n | Events | Rate % | OR |
|---|---|---|---|---|
| Female | 891 | 104 | 22.7 | 0.56 |
| Female | 449 | 94 | 38.4 | 0.65 |
| Centre A | 720 | 90 | 28.5 | 0.92 |
| Centre B | 776 | 93 | 38.1 | 0.53 |
| Male | 610 | 100 | 7.2 | 0.60 |
| Intervention | 196 | 52 | 14.3 | 0.96 |
| Age ≥ 65 | 710 | 79 | 38.0 | 0.53 |
Values are n (%) unless stated otherwise.

Shown for older adults; error bars are 95% confidence intervals.
2844 participants were included (median age 77 years). Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.92 (95% CI 0.37 to 0.62).